{"transactions":[{"id":911503,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-10T19:10:50.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"2/48th of the shares subject to such option shall vest and become exercisable on March 1, 2026 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":125000,"derivative":{"exercise_price":25.41,"exercise_date":"2026-02-06","expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001193125-26-045109","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000119312526045109/ownership.xml","form_type":"4"}},{"id":991100,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-11-21T16:36:59.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options fully vest on December 1, 2026."}],"balance_after":12000,"derivative":{"exercise_price":10.16,"expiration_date":"2035-11-19","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000912282-25-001279","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225001279/form4.xml","form_type":"4"}},{"id":991099,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Shares","published_at":"2025-11-21T16:36:59.000Z","date":"2025-11-19","kind":"grant","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which fully vest on December 1, 2026."}],"balance_after":55500,"source":{"system":"sec-edgar","filing":"0000912282-25-001279","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225001279/form4.xml","form_type":"4"}},{"id":1069905,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-08-11T19:06:48.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"6/48th of the shares subject to such option shall vest and become exercisable on February 1, 2026 and the remaining shares subject to the option shall vest in 42 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date."}],"balance_after":37500,"derivative":{"exercise_price":11.7,"expiration_date":"2035-08-06","underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0000950170-25-106795","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025106795/ownership.xml","form_type":"4"}},{"id":1111157,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-06-13T14:15:55.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on July 1, 2026."}],"balance_after":5000,"derivative":{"exercise_price":4.39,"expiration_date":"2035-06-10","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0000912282-25-000664","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225000664/form4.xml","form_type":"4"}},{"id":1111156,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-06-13T14:15:55.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":9000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which vest 100% on July 1, 2026."}],"balance_after":34500,"source":{"system":"sec-edgar","filing":"0000912282-25-000664","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225000664/form4.xml","form_type":"4"}},{"id":1240271,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-27T18:51:11.000Z","date":"2025-02-27","kind":"purchase","planned":false,"acquired":true,"shares":3718,"price":5.85,"value":21750.3,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":40000,"source":{"system":"sec-edgar","filing":"0000950170-25-029330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025029330/ownership.xml","form_type":"4"}},{"id":1240270,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-27T18:51:11.000Z","date":"2025-02-25","kind":"purchase","planned":false,"acquired":true,"shares":6282,"price":5.59,"value":35116.38,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.50 to $5.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":36282,"source":{"system":"sec-edgar","filing":"0000950170-25-029330","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025029330/ownership.xml","form_type":"4"}},{"id":1252418,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-21T18:06:31.000Z","date":"2025-02-21","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":5.85,"value":29250.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.77 to $5.88. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0000950170-25-025039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025025039/ownership.xml","form_type":"4"}},{"id":1252417,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-21T18:06:31.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":14500,"price":5.8782,"value":85233.9,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.58 to $6.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0000950170-25-025039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025025039/ownership.xml","form_type":"4"}},{"id":1252416,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-02-21T18:06:31.000Z","date":"2025-02-19","kind":"purchase","planned":false,"acquired":true,"shares":10500,"price":5.506,"value":57813.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.48 to $5.54. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of such shares for purposes of Section 16 except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose."}],"balance_after":10500,"source":{"system":"sec-edgar","filing":"0000950170-25-025039","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025025039/ownership.xml","form_type":"4"}},{"id":1255262,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2025-02-20T11:10:46.000Z","date":"2025-02-16","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest 100% on March 1, 2026."}],"balance_after":15000,"derivative":{"exercise_price":4.61,"expiration_date":"2035-02-16","underlying":"Common Shares","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0000912282-25-000184","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225000184/form4.xml","form_type":"4"}},{"id":1255261,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true}}],"security":"Common Shares","published_at":"2025-02-20T11:10:46.000Z","date":"2025-02-16","kind":"grant","planned":false,"acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units which vest 100% on March 1, 2026."}],"balance_after":25500,"source":{"system":"sec-edgar","filing":"0000912282-25-000184","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228225000184/form4.xml","form_type":"4"}},{"id":1278481,"issuer":{"id":2452,"kind":"organization","name":"Septerna, Inc.","symbol":"SEPN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-07T16:37:18.000Z","date":"2025-02-07","kind":"grant","planned":false,"acquired":true,"shares":222000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares underlying this option will vest on January 6, 2026, and the remaining 75% of the shares underlying this option will vest in thirty-six substantially equal monthly installments thereafter, subject to the Reporting Person's continuous service to the Issuer on each such vesting date."}],"balance_after":222000,"derivative":{"exercise_price":13.09,"expiration_date":"2035-02-06","underlying":"Common Stock","underlying_shares":222000},"source":{"system":"sec-edgar","filing":"0000950170-25-016362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000095017025016362/ownership.xml","form_type":"4"}},{"id":1415319,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-09-04T20:36:13.000Z","date":"2024-08-31","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on August 31, 2025, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":150000,"derivative":{"exercise_price":4.78,"expiration_date":"2034-08-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001962918-24-000112","document":"wk-form4_1725493118.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000196291824000112/wk-form4_1725493118.xml","form_type":"4"}},{"id":1501602,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO and CBO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-05-24T18:59:17.000Z","date":"2024-05-23","kind":"grant","planned":false,"acquired":true,"shares":184042,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"33% of the shares subject to the option vest on December 15, 2024, 34% of the shares subject to the option vest on June 15, 2025, and the remaining 33% of the shares subject to the option vest on December 15, 2025, subject to the Reporting Person's continued service."}],"balance_after":184042,"derivative":{"exercise_price":4.22,"expiration_date":"2034-05-22","underlying":"Common Stock","underlying_shares":184042},"source":{"system":"sec-edgar","filing":"0001962918-24-000065","document":"wk-form4_1716591539.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000196291824000065/wk-form4_1716591539.xml","form_type":"4"}},{"id":1670709,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-01-25T12:08:24.000Z","date":"2024-01-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest in 36 equal monthly installments, beginning February 23, 2024."}],"balance_after":30000,"derivative":{"exercise_price":1.02,"expiration_date":"2034-01-23","underlying":"Common Shares","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0000912282-24-000079","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000091228224000079/form4.xml","form_type":"4"}},{"id":1680589,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-01-11T18:26:23.000Z","date":"2024-01-09","kind":"grant","planned":false,"acquired":true,"shares":855513,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on January 9, 2025, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service."}],"balance_after":855513,"derivative":{"exercise_price":7.68,"expiration_date":"2034-01-08","underlying":"Common Stock","underlying_shares":855513},"source":{"system":"sec-edgar","filing":"0001962918-24-000004","document":"wk-form4_1705015575.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000196291824000004/wk-form4_1705015575.xml","form_type":"4"}},{"id":1763363,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-06T17:53:54.000Z","date":"2023-10-04","kind":"other","planned":false,"acquired":true,"shares":40763,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a pro rata, in-kind distribution, and not a purchase or sale of securities, from Woodland Hills Partner LLC (the \"LLC\") to the Reporting Person, a limited partner of the LLC, without additional consideration. This distribution arises from the purchase of preferred stock by the Reporting Person as a limited partner in the LLC on the same pricing terms as the other participating investors in each round of financing."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held directly by The Labrucherie Trust dated 9/1/2009, for which the Reporting Person serves as trustee."}],"balance_after":40763,"source":{"system":"sec-edgar","filing":"0001962918-23-000034","document":"wk-form4_1696629224.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000196291823000034/wk-form4_1696629224.xml","form_type":"4"}},{"id":1800541,"issuer":{"id":79310,"kind":"organization","name":"ACELYRIN, Inc.","symbol":"SLRN"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-08-21T16:48:44.000Z","date":"2023-08-17","kind":"grant","planned":false,"acquired":true,"shares":254939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/4 of the shares subject to the option vest on August 17, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service through each vesting date."}],"balance_after":254939,"derivative":{"exercise_price":26.94,"expiration_date":"2033-08-16","underlying":"Common Stock","underlying_shares":254939},"source":{"system":"sec-edgar","filing":"0001962918-23-000029","document":"wk-form4_1692650915.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000196291823000029/wk-form4_1692650915.xml","form_type":"4"}},{"id":2220936,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-27T17:43:11.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Option will become vested and exercisable as follows: one thirty-sixth (1/36) of such Option shall vest on the first day of the month following the Grant Date and each month thereafter on the first day of each month until the Option is 100% vested. The unvested portion of the Option will not be exercisable on or after the Director's termination of Continuous Service."}],"balance_after":80000,"derivative":{"exercise_price":3.4,"expiration_date":"2032-06-23","underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001567619-22-013409","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000156761922013409/doc1.xml","form_type":"4"}},{"id":2269049,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2022-05-18T01:32:02.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":17448,"price":3.95,"value":68919.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $3.86 to $4.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":312905,"source":{"system":"sec-edgar","filing":"0001209191-22-029899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919122029899/doc4.xml","form_type":"4"}},{"id":2269048,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2022-05-18T01:32:02.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":28750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common stock was acquired pursuant to a grant of restricted stock units (\"RSU\"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 14, 2018 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the \"2017 Plan\") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three (3) years from the date of grant."},{"field":"date","element":"transactionDate","label":"F2","text":"The Organization and Compensation Committee of the Board of Directors of the Issuer determined that the performance-based vesting requirement for these RSUs was satisfied on May 13, 2022. Pursuant to the terms of the 2017 Plan, these RSUs vested on the next quarterly vesting date (May 15, 2022) following the date that the performance-based vesting requirement was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":330353,"source":{"system":"sec-edgar","filing":"0001209191-22-029899","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919122029899/doc4.xml","form_type":"4"}},{"id":2277310,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-09T16:28:06.000Z","date":"2022-05-04","kind":"purchase","acquired":true,"shares":52631,"price":3.8,"value":199997.8,"ownership":{"direct":false,"nature":"The Labrucherie Trust dated 9/1/2009"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired these shares of common stock in connection with the Issuer's closing of registered direct public offering on May 4, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Issuer effected a 50:1 reverse stock split on October 9, 2020.  Reporting Person's indirect holdings following the split were 941 shares."}],"balance_after":53572,"source":{"system":"sec-edgar","filing":"0001567619-22-009789","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000156761922009789/doc1.xml","form_type":"4/A","original_submission_date":"2022-05-06"}},{"id":2279053,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T17:15:55.000Z","date":"2022-05-04","kind":"purchase","acquired":true,"shares":52631,"price":3.8,"value":199997.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Reporting Person acquired these shares of common stock in connection with the Issuer's closing of registered direct public offering on May 4, 2022."}],"balance_after":52631,"source":{"system":"sec-edgar","filing":"0001567619-22-009699","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000156761922009699/doc1.xml","form_type":"4"}},{"id":2386433,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2022-02-18T23:14:01.000Z","date":"2022-02-16","kind":"sale","acquired":false,"shares":7579,"price":10.95,"value":82990.05,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.77 to $11.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":301603,"source":{"system":"sec-edgar","filing":"0001209191-22-011436","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919122011436/doc4.xml","form_type":"4"}},{"id":2464490,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-12-21T01:23:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":94000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years from the date of grant in equal monthly installments based on continued service."}],"balance_after":94000,"derivative":{"exercise_price":13.22,"expiration_date":"2029-12-15","underlying":"Common Stock","underlying_shares":94000},"source":{"system":"sec-edgar","filing":"0001209191-21-070690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121070690/doc4.xml","form_type":"4"}},{"id":2464489,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-12-21T01:23:27.000Z","date":"2021-12-16","kind":"grant","acquired":true,"shares":52950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the Issuer's common stock.  These RSUs vest over three years from the date of grant in substantially equal quarterly installments based on continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":309182,"source":{"system":"sec-edgar","filing":"0001209191-21-070690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121070690/doc4.xml","form_type":"4"}},{"id":2505490,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-11-18T23:06:19.000Z","date":"2021-11-18","kind":"sale","acquired":false,"shares":3000,"price":12.69,"value":38070.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":256682,"source":{"system":"sec-edgar","filing":"0001209191-21-065592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121065592/doc4.xml","form_type":"4"}},{"id":2505489,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-11-18T23:06:19.000Z","date":"2021-11-16","kind":"sale","acquired":false,"shares":21149,"price":13.16,"value":278320.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.84 to $13.52. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":259682,"source":{"system":"sec-edgar","filing":"0001209191-21-065592","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121065592/doc4.xml","form_type":"4"}},{"id":2508836,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-11-17T23:04:58.000Z","date":"2021-11-15","kind":"grant","acquired":true,"shares":40150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common stock was acquired pursuant to a grant of restricted stock units (\"RSU\"). Each RSU awarded represents a contingent right to receive, upon vesting of the unit, one share of Common Stock of the Issuer. These RSUs were granted on December 12, 2019 under the Issuer's Amended and Restated 2017 Performance Incentive Plan (the \"2017 Plan\") and at the time of their grant were subject to both performance-based and time-based vesting requirements. The time-based vesting is on a quarterly pro-rata basis over a period of three (3) years from the date of grant."},{"field":"date","element":"transactionDate","label":"F2","text":"The Organization and Compensation Committee of the Board of Directors of the Issuer determined that the performance-based vesting requirement for these RSUs was satisfied on September 15, 2021. Pursuant to the terms of the 2017 Plan, these RSUs vested on the next quarterly vesting date (November 15, 2021) following the date that the performance-based vesting requirement was satisfied."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":280831,"source":{"system":"sec-edgar","filing":"0001209191-21-065220","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121065220/doc4.xml","form_type":"4"}},{"id":2542851,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-10-15T01:05:22.000Z","date":"2021-10-12","kind":"grant","acquired":true,"shares":71550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These stock options were granted on December 12, 2019 under the Company's Amended and Restated 2017 Performance Incentive Plan (the \"2017 Plan\") and at the time of their grant were subject to both performance-based and time-based vesting requirements."},{"field":"date","element":"transactionDate","label":"F2","text":"The Organization and Compensation Committee of the Board of Directors of the Company determined that the performance-based vesting requirement for these stock options was satisfied on September 15, 2021. Pursuant to the terms of the 2017 Plan, these stock options vested on the next monthly vesting date (October 12, 2021) following the date that the performance-based vesting requirement was satisfied."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These stock options vest on a monthly pro-rata basis over a period of four years from the grant date (December 12, 2019)."}],"balance_after":71550,"derivative":{"exercise_price":21.79,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":71550},"source":{"system":"sec-edgar","filing":"0001209191-21-060509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121060509/doc4.xml","form_type":"4"}},{"id":2598722,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-08-18T22:58:33.000Z","date":"2021-08-17","kind":"sale","acquired":false,"shares":3000,"price":13.56,"value":40680.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":240231,"source":{"system":"sec-edgar","filing":"0001209191-21-052384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121052384/doc4.xml","form_type":"4"}},{"id":2598721,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-08-18T22:58:33.000Z","date":"2021-08-16","kind":"sale","acquired":false,"shares":7867,"price":13.83,"value":108800.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $13.69 to $14.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":243231,"source":{"system":"sec-edgar","filing":"0001209191-21-052384","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121052384/doc4.xml","form_type":"4"}},{"id":2633886,"issuer":{"id":1990,"kind":"organization","name":"Rezolute, Inc.","symbol":"RZLT"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-07-14T21:03:11.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option will become vested and exercisable as follows:  one thirty-sixth (1/36) of such Options shall vest on the first day of the month following the Grant Date and each month thereafter on the first day of each month until the Option is 100% vested.  The unvested portion of the Option will not be exercisable on or after the Director's termination of Continuous Service."}],"balance_after":5000,"derivative":{"exercise_price":12.28,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001567619-21-013437","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1394875/000156761921013437/doc1.xml","form_type":"4"}},{"id":2706435,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-05-19T23:04:00.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":7898,"price":18.3,"value":144533.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.95 to $18.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":251098,"source":{"system":"sec-edgar","filing":"0001209191-21-034184","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121034184/doc4.xml","form_type":"4"}},{"id":2852034,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-19T00:03:05.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":7977,"price":22.37,"value":178445.49,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.04 to $22.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":258996,"source":{"system":"sec-edgar","filing":"0001209191-21-012119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121012119/doc4.xml","form_type":"4"}},{"id":2879742,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-04","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."}],"balance_after":0,"derivative":{"exercise_price":8.8,"exercise_date":"2017-02-06","expiration_date":"2021-02-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879741,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."}],"balance_after":50000,"derivative":{"exercise_price":8.8,"exercise_date":"2017-02-06","expiration_date":"2021-02-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879740,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."}],"balance_after":0,"derivative":{"exercise_price":8.8,"exercise_date":"2017-02-06","expiration_date":"2021-02-05","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879739,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-02","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."}],"balance_after":25000,"derivative":{"exercise_price":8.8,"exercise_date":"2017-02-06","expiration_date":"2021-02-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879738,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":50000,"price":19.81,"value":990500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"This transaction was executed in multiple trades at prices ranging from $19.50 to $20.19. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."}],"balance_after":266973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879737,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-04","kind":"exercise","acquired":true,"shares":50000,"price":8.8,"value":440000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":316973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879736,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-03","kind":"sale","acquired":false,"shares":50000,"price":19.61,"value":980500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"This transaction was executed in multiple trades at prices ranging from $19.30 to $19.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":266973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879735,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":25000,"price":8.8,"value":220000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":316973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879734,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-03","kind":"exercise","acquired":true,"shares":25000,"price":8.8,"value":220000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":291973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879733,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":1933,"price":21.66,"value":41868.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $21.57 to $21.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":266973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879732,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":6932,"price":20.96,"value":145294.72,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $20.56 to $21.56.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":268906,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879731,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-02","kind":"sale","acquired":false,"shares":41135,"price":19.97,"value":821465.95,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $19.55 to $20.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":275838,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2879730,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2021-02-05T01:42:52.000Z","date":"2021-02-02","kind":"exercise","acquired":true,"shares":50000,"price":8.8,"value":440000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for certain options expiring on February 5, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":316973,"source":{"system":"sec-edgar","filing":"0001209191-21-007942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919121007942/doc4.xml","form_type":"4"}},{"id":2935278,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2020-12-22T23:48:30.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":71500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":71500,"derivative":{"exercise_price":18.75,"expiration_date":"2028-12-17","underlying":"Common Stock","underlying_shares":71500},"source":{"system":"sec-edgar","filing":"0001209191-20-064913","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120064913/doc4.xml","form_type":"4"}},{"id":2935277,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-12-22T23:48:30.000Z","date":"2020-12-18","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.  These RSUs vest over three years in substantially equal quarterly installments based on continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":266973,"source":{"system":"sec-edgar","filing":"0001209191-20-064913","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120064913/doc4.xml","form_type":"4"}},{"id":2976252,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-11-19T00:03:32.000Z","date":"2020-11-16","kind":"sale","acquired":false,"shares":8276,"price":16.93,"value":140112.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $16.71 to $17.46. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":226973,"source":{"system":"sec-edgar","filing":"0001209191-20-059241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120059241/doc4.xml","form_type":"4"}},{"id":3026362,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-09-22T00:59:32.000Z","date":"2020-09-17","kind":"sale","acquired":false,"shares":2000,"price":19.96,"value":39920.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.90 to $20.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":235249,"source":{"system":"sec-edgar","filing":"0001209191-20-051389","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120051389/doc4.xml","form_type":"4"}},{"id":3052949,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-08-19T22:37:58.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":2000,"price":19.68,"value":39360.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":237249,"source":{"system":"sec-edgar","filing":"0001209191-20-047613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120047613/doc4.xml","form_type":"4"}},{"id":3052948,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-08-19T22:37:58.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":6245,"price":19.67,"value":122839.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $19.35 to $19.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":239249,"source":{"system":"sec-edgar","filing":"0001209191-20-047613","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120047613/doc4.xml","form_type":"4"}},{"id":3141516,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-05-20T22:29:53.000Z","date":"2020-05-19","kind":"sale","acquired":false,"shares":2000,"price":22.62,"value":45240.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":245494,"source":{"system":"sec-edgar","filing":"0001209191-20-031014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120031014/doc4.xml","form_type":"4"}},{"id":3141515,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-05-20T22:29:53.000Z","date":"2020-05-18","kind":"sale","acquired":false,"shares":5727,"price":22.51,"value":128914.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.29 to $22.76. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":247494,"source":{"system":"sec-edgar","filing":"0001209191-20-031014","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120031014/doc4.xml","form_type":"4"}},{"id":3260726,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2020-02-20T23:37:40.000Z","date":"2020-02-18","kind":"sale","acquired":false,"shares":5938,"price":22.35,"value":132714.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $22.00 to $23.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":253221,"source":{"system":"sec-edgar","filing":"0001209191-20-011258","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919120011258/doc4.xml","form_type":"4"}},{"id":3341468,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2019-12-17T02:34:20.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":29000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":29000,"derivative":{"exercise_price":21.79,"expiration_date":"2017-12-11","underlying":"Common Stock","underlying_shares":29000},"source":{"system":"sec-edgar","filing":"0001209191-19-060787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119060787/doc4.xml","form_type":"4"}},{"id":3341467,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2019-12-17T02:34:20.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":71550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":71550,"derivative":{"exercise_price":21.79,"expiration_date":"2027-12-11","underlying":"Common Stock","underlying_shares":71550},"source":{"system":"sec-edgar","filing":"0001209191-19-060787","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119060787/doc4.xml","form_type":"4"}},{"id":3341466,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-12-17T02:34:20.000Z","date":"2019-12-12","kind":"grant","acquired":true,"shares":40150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.  These RSUs vest over three years in substantially equal quarterly installments based on continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":259159,"source":{"system":"sec-edgar","filing":"0001209191-19-060787","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119060787/doc4.xml","form_type":"4"}},{"id":3364754,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-11-21T00:04:43.000Z","date":"2019-11-18","kind":"sale","acquired":false,"shares":8863,"price":17.97,"value":159268.11,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.56 to $19.65. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":219009,"source":{"system":"sec-edgar","filing":"0001209191-19-057489","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119057489/doc4.xml","form_type":"4"}},{"id":3370482,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2019-11-15T23:09:15.000Z","date":"2019-11-13","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":0,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-056807","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/doc4.xml","form_type":"4"}},{"id":3370481,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-11-15T23:09:15.000Z","date":"2019-11-13","kind":"sale","acquired":false,"shares":25000,"price":19.79,"value":494750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $19.35 to $20.24. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":227872,"source":{"system":"sec-edgar","filing":"0001209191-19-056807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/doc4.xml","form_type":"4"}},{"id":3370480,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-11-15T23:09:15.000Z","date":"2019-11-13","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":252872,"source":{"system":"sec-edgar","filing":"0001209191-19-056807","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119056807/doc4.xml","form_type":"4"}},{"id":3392429,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2019-10-17T22:59:43.000Z","date":"2019-10-15","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":25000,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-053497","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/doc4.xml","form_type":"4"}},{"id":3392428,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-10-17T22:59:43.000Z","date":"2019-10-15","kind":"sale","acquired":false,"shares":25000,"price":15.83,"value":395750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":227872,"source":{"system":"sec-edgar","filing":"0001209191-19-053497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/doc4.xml","form_type":"4"}},{"id":3392427,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-10-17T22:59:43.000Z","date":"2019-10-15","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":252872,"source":{"system":"sec-edgar","filing":"0001209191-19-053497","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119053497/doc4.xml","form_type":"4"}},{"id":3401816,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Stock Option","published_at":"2019-10-02T23:30:18.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":150000,"derivative":{"exercise_price":18.43,"expiration_date":"2027-09-30","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0000899243-19-024776","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924319024776/doc4.xml","form_type":"4"}},{"id":3401815,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, COO & CFO"}}],"security":"Common Stock","published_at":"2019-10-02T23:30:18.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock. These RSUs vest over three years in substantially equal quarterly installments based on continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":227872,"source":{"system":"sec-edgar","filing":"0000899243-19-024776","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000089924319024776/doc4.xml","form_type":"4"}},{"id":3411276,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-09-18T23:07:05.000Z","date":"2019-09-16","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":50000,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-050149","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/doc4.xml","form_type":"4"}},{"id":3411275,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-18T23:07:05.000Z","date":"2019-09-16","kind":"sale","acquired":false,"shares":25000,"price":20.52,"value":513000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $20.05 to $20.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":152872,"source":{"system":"sec-edgar","filing":"0001209191-19-050149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/doc4.xml","form_type":"4"}},{"id":3411274,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-09-18T23:07:05.000Z","date":"2019-09-16","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":177872,"source":{"system":"sec-edgar","filing":"0001209191-19-050149","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119050149/doc4.xml","form_type":"4"}},{"id":3428698,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-08-27T21:20:27.000Z","date":"2019-08-26","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":57500,"derivative":{"exercise_price":16.31,"exercise_date":"2018-12-09","expiration_date":"2022-12-08","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-19-047553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119047553/doc4.xml","form_type":"4"}},{"id":3428697,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-27T21:20:27.000Z","date":"2019-08-26","kind":"exercise","acquired":true,"shares":30000,"price":16.31,"value":489300.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":152872,"source":{"system":"sec-edgar","filing":"0001209191-19-047553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119047553/doc4.xml","form_type":"4"}},{"id":3435065,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-19T23:07:10.000Z","date":"2019-08-16","kind":"sale","acquired":false,"shares":5063,"price":18.15,"value":91893.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $17.87 to $18.37. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":122872,"source":{"system":"sec-edgar","filing":"0001209191-19-046715","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119046715/doc4.xml","form_type":"4"}},{"id":3436748,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-08-17T00:13:31.000Z","date":"2019-08-14","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":0,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-046428","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/doc4.xml","form_type":"4"}},{"id":3436747,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-17T00:13:31.000Z","date":"2019-08-14","kind":"sale","acquired":false,"shares":25000,"price":17.79,"value":444750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $17.31 to $18.64. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":127935,"source":{"system":"sec-edgar","filing":"0001209191-19-046428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/doc4.xml","form_type":"4"}},{"id":3436746,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-08-17T00:13:31.000Z","date":"2019-08-14","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":152935,"source":{"system":"sec-edgar","filing":"0001209191-19-046428","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119046428/doc4.xml","form_type":"4"}},{"id":3463268,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-07-12T22:31:26.000Z","date":"2019-07-10","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":25000,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-041988","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/doc4.xml","form_type":"4"}},{"id":3463267,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-12T22:31:26.000Z","date":"2019-07-10","kind":"sale","acquired":false,"shares":25000,"price":34.57,"value":864250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $34.10 to $35.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":127935,"source":{"system":"sec-edgar","filing":"0001209191-19-041988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/doc4.xml","form_type":"4"}},{"id":3463266,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-07-12T22:31:26.000Z","date":"2019-07-10","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":152935,"source":{"system":"sec-edgar","filing":"0001209191-19-041988","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119041988/doc4.xml","form_type":"4"}},{"id":3485258,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2019-06-19T21:50:57.000Z","date":"2019-06-17","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."}],"balance_after":50000,"derivative":{"exercise_price":7.21,"exercise_date":"2016-02-08","expiration_date":"2020-02-07","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-19-038099","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/doc4.xml","form_type":"4"}},{"id":3485257,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-19T21:50:57.000Z","date":"2019-06-17","kind":"sale","acquired":false,"shares":25000,"price":33.71,"value":842750.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $33.37 to $33.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":127935,"source":{"system":"sec-edgar","filing":"0001209191-19-038099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/doc4.xml","form_type":"4"}},{"id":3485256,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-19T21:50:57.000Z","date":"2019-06-17","kind":"exercise","acquired":true,"shares":25000,"price":7.21,"value":180250.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Labrucherie for stock options scheduled to expire on February 7, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":152935,"source":{"system":"sec-edgar","filing":"0001209191-19-038099","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119038099/doc4.xml","form_type":"4"}},{"id":3522247,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-05-18T00:20:38.000Z","date":"2019-05-16","kind":"sale","acquired":false,"shares":3767,"price":31.37,"value":118170.79,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $30.86 to $32.68. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":127935,"source":{"system":"sec-edgar","filing":"0001209191-19-031187","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119031187/doc4.xml","form_type":"4"}},{"id":3643135,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-02-22T01:14:50.000Z","date":"2019-02-19","kind":"sale","acquired":false,"shares":3592,"price":42.39,"value":152264.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $41.90 to $42.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":131702,"source":{"system":"sec-edgar","filing":"0001209191-19-012334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919119012334/doc4.xml","form_type":"4"}},{"id":3727832,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-12-18T23:12:39.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":58100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This stock option vests over four years in equal monthly installments based on continued service."}],"balance_after":58100,"derivative":{"exercise_price":36.51,"expiration_date":"2026-12-13","underlying":"Common Stock","underlying_shares":58100},"source":{"system":"sec-edgar","filing":"0001209191-18-063300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118063300/doc4.xml","form_type":"4"}},{"id":3727831,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-12-18T23:12:39.000Z","date":"2018-12-14","kind":"grant","acquired":true,"shares":28750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This stock award was acquired pursuant to a grant of restricted stock units (\"RSUs\"). Each RSU represents a contingent right to receive, upon vesting of the unit, one share of the issuer's common stock.  These RSUs vest over three years in substantially equal quarterly installments based on continued service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":135294,"source":{"system":"sec-edgar","filing":"0001209191-18-063300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118063300/doc4.xml","form_type":"4"}},{"id":3759845,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-19T23:13:22.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":6515,"price":38.25,"value":249198.75,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $37.47 to $38.97. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":106544,"source":{"system":"sec-edgar","filing":"0001209191-18-059290","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118059290/doc4.xml","form_type":"4"}},{"id":3842483,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-08-17T01:45:33.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"These options, at the time of their grant were subject to both performance-based and time-based vesting requirements.   On August 15, 2018, the performance-based condition vesting was satisfied.  The time-based vesting is on a monthly pro-rata basis over a period of four years from the grant date (December 15, 2017)."},{"field":"date","element":"transactionDate","label":"F6","text":"These stock options were granted on December 15, 2017 and the performance-based vesting requirement for these stock options was satisfied on August 15, 2018 upon the Compensation Committee's certification of the successful acceptance of the New Drug Application by the FDA for NKTR-181."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This stock option vests on a monthly pro-rata basis over a period of four years from the grant date."}],"balance_after":65000,"derivative":{"exercise_price":56.9,"expiration_date":"2025-12-14","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001209191-18-047241","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047241/doc4.xml","form_type":"4"}},{"id":3842482,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T01:45:33.000Z","date":"2018-08-16","kind":"disposition_to_issuer","acquired":false,"shares":8207,"price":58.4,"value":479288.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $56.37 to $59.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":113059,"source":{"system":"sec-edgar","filing":"0001209191-18-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047241/doc4.xml","form_type":"4"}},{"id":3842481,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T01:45:33.000Z","date":"2018-08-15","kind":"grant","acquired":true,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units (\"RSUs\"), convertible on a one-for-one basis into shares of Common Stock of the Company. These RSUs, at the time of their grant on December 15, 2017, were subject to both performance-based and time-based vesting requirements.  On August 15, 2018, the performance-based condition vesting was satisfied. The time-based vesting is on a quarterly pro-rata basis over a period of three (3) years from the date of grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 4,218 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":121266,"source":{"system":"sec-edgar","filing":"0001209191-18-047241","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118047241/doc4.xml","form_type":"4"}},{"id":3926603,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-18T23:03:53.000Z","date":"2018-05-16","kind":"sale","acquired":false,"shares":4941,"price":83.39,"value":412029.99,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs held by the reporting person. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $81.35 to $84.80. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":94798,"source":{"system":"sec-edgar","filing":"0001209191-18-031594","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118031594/doc4.xml","form_type":"4"}},{"id":3948435,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-05-04T00:43:40.000Z","date":"2018-05-03","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months."}],"balance_after":0,"derivative":{"exercise_price":10.69,"exercise_date":"2015-02-08","expiration_date":"2019-02-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-027942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118027942/doc4.xml","form_type":"4"}},{"id":3948434,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-05-04T00:43:40.000Z","date":"2018-05-02","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months."}],"balance_after":30000,"derivative":{"exercise_price":10.69,"exercise_date":"2015-02-08","expiration_date":"2019-02-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-027942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118027942/doc4.xml","form_type":"4"}},{"id":3948433,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Stock Option","published_at":"2018-05-04T00:43:40.000Z","date":"2018-05-01","kind":"exercise","acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months."}],"balance_after":60000,"derivative":{"exercise_price":10.69,"exercise_date":"2015-02-08","expiration_date":"2019-02-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-18-027942","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118027942/doc4.xml","form_type":"4"}},{"id":3948432,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-04T00:43:40.000Z","date":"2018-05-03","kind":"sale","acquired":false,"shares":30000,"price":82.86,"value":2485800.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $81.37 to $84.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":99739,"source":{"system":"sec-edgar","filing":"0001209191-18-027942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118027942/doc4.xml","form_type":"4"}},{"id":3948431,"issuer":{"id":4364,"kind":"organization","name":"NEKTAR THERAPEUTICS","symbol":"NKTR"},"owners":[{"id":67014,"kind":"person","name":"Labrucherie Gil M","position":1,"cik":"0001394875","reported_name":"Labrucherie Gil M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP & Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-05-04T00:43:40.000Z","date":"2018-05-03","kind":"exercise","acquired":true,"shares":30000,"price":10.69,"value":320700.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person for options expiring in the next 12 months."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This number includes 997 shares held by the reporting person in the Issuer's 401(K) plan and 3,750 shares held by the reporting person in the Issuer's ESPP plan. The acquisition of these shares under both plans is exempt under Rule 16b-3(c)."}],"balance_after":129739,"source":{"system":"sec-edgar","filing":"0001209191-18-027942","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/906709/000120919118027942/doc4.xml","form_type":"4"}}],"next_cursor":"2018-05-04T00:43:40.000000Z,3948431"}